Reproductive BioMedicine Online
Volume 21, Issue 5 , Pages 636-641, November 2010

Outcomes of vitrified–warmed day-4 embryos after day-3 cleavage-stage biopsy

  • Semra Kahraman

      Affiliations

    • Corresponding Author InformationCorresponding author.
  • ,
  • Zafer Nihat Candan

      Affiliations

    • Present address: Istanbul Memorial Hospital, ART and Reproductive Genetics Center, Piyale Pasa Bulvari, Okmeydani, 34385 Istanbul, Turkey.

Istanbul Memorial Hospital, ART and Reproductive Genetics Unit, Istanbul, Turkey

Received 30 December 2009; received in revised form 9 July 2010; accepted 13 July 2010. published online 02 August 2010.

Declaration: The authors report no financial or commercial conflicts of interest.

Abstract 

The objective of this study was to compare the post-warming survival rates of biopsied and non-biopsied day-3 embryos vitrified on day 4 and to evaluate the clinical outcomes of following transfers. This study included 18 preimplantation genetic diagnosis (PGD) patients and 18 non-PGD patients treated between January 2005 and January 2009 who had not achieved live births during their fresh embryo-transfer cycles and whose surplus embryos were cryopreserved on day 4. The embryo survival rate after warming in the PGD and non-PGD groups was similar (53/59, 89.8% versus 55/64, 85.9%, respectively; difference of 3.9% 95% CI −7.3 to 13.4). Vitrified embryo-transfer cycles yielded no significant differences between PGD and non-PGD groups in implantation rates (12/46, 26.1% versus 9/47, 19.1%, respectively; difference of 6.9%, 95% CI −9.7 to 22.2), clinical pregnancy rates (11/18, 61.1% versus 9/18, 50%, respectively; difference of 11.1%, 95% CI −20.6 to 40.6) and live birth rates (9/18, 50% versus 6/18, 33.3%, respectively; difference of 16.7%, 95% CI −15.1 to 44.8). These results showed that, in PGD cycles, embryos can be vitrified effectively on day 4 after biopsy on day 3.

The objective of this study was to compare the post-warming survival rates of biopsied and non-biopsied day-3 embryos that vitrified on day 4 and to evaluate the clinical outcomes of following transfers. This retrospective study included 18 preimplantation genetic diagnosis (PGD) and 18 non-PGD patients treated between January 2005 and January 2009 who had not achieved live births during their fresh embryo transfer cycles and whose surplus were frozen on day 4. After warming in frozen embryo-transfer cycles, embryo survival with respect to embryo grades, implantation, clinical pregnancy and live birth rates were compared. The embryo survival rate after warming in the PGD group was similar to the survival rate in the non-PGD group (53/59, 89.8% versus 55/64, 85.9%, respectively; difference of 3.9%, 95% CI −7.3 to 13.4, P=0.701). Frozen embryo transfer yielded no significant differences between PGD and non-PGD groups in implantation rates (12/46, 26.1% versus 9/47, 19.1%, respectively; difference of 6.9%, 95% CI −9.7 to 22.2, P=0.581), clinical pregnancy rates (11/18, 61.1% versus 9/18, 50%, respectively; difference of 11.1%, 95% CI −20.6 to 40.6, P=0.737) or live birth rates (9/18, 50% versus 6/18, 33.3%, respectively; difference of 16.7%, 95% CI −15.1 to 44.8, P=0.499). These results showed that, in PGD cycles, embryos can be vitrified effectively on day 4 after biopsy on day 3.

Keywords: cleavage stage, day-4 embryo, embryo biopsy, post-warming survival rate, vitrification

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Semra Kahraman graduated from Hacettepe University Medical School and obtained her speciality degree in obstetrics and gynaecology from Ankara University Medical School. She is Professor and Senior Lecturer at Yeditepe University School of Medicine. She is the first in Turkey to have carried out ICSI, embryo freezing and testing for aneuploidy and single-gene disorders. She is the director of Reproductive Endocrinology and Genetics Unit at Istanbul Memorial Hospital ART, in which more than 3000 assisted cycles are performed annually, and a board member of Preimplantation Genetic Diagnosis International Society.

PII: S1472-6483(10)00509-2

doi:10.1016/j.rbmo.2010.07.011

Reproductive BioMedicine Online
Volume 21, Issue 5 , Pages 636-641, November 2010